SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-20-005794
Filing Date
2020-08-10
Accepted
2020-08-10 17:24:16
Documents
48
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q xbit20200630_10q.htm   iXBRL 10-Q 933472
2 EXHIBIT 31.1 ex_197741.htm EX-31.1 10434
3 EXHIBIT 31.2 ex_197742.htm EX-31.2 10268
4 EXHIBIT 32.1 ex_197743.htm EX-32.1 6046
  Complete submission text file 0001171843-20-005794.txt   3917633

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA xbit-20200630.xsd EX-101.SCH 31227
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE xbit-20200630_cal.xml EX-101.CAL 29834
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xbit-20200630_def.xml EX-101.DEF 253889
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE xbit-20200630_lab.xml EX-101.LAB 221346
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xbit-20200630_pre.xml EX-101.PRE 270351
10 EXTRACTED XBRL INSTANCE DOCUMENT xbit20200630_10q_htm.xml XML 522717
Mailing Address 8201 E. RIVERSIDE DRIVE BUILDING 4, SUITE 100 AUSTIN TX 78744
Business Address 8201 E. RIVERSIDE DRIVE BUILDING 4, SUITE 100 AUSTIN TX 78744 512-386-2930
XBiotech Inc. (Filer) CIK: 0001626878 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37347 | Film No.: 201090423
SIC: 2834 Pharmaceutical Preparations